share run last year believ lot
posit price feel solid year new product
launch earn power aler potenti benefit tax reform
may occur said mani posit happen share reflect
reach previous rais pt trade
peer share may go bit higher see anoth
upsid next month thu move neutral
mani thing gone right pick coverag felt
number thing could occur push share higher includ
mitraclip benefit competit delay continu libr
get approv occur neuromod pick steam continu
mri safe approv occur de face weak comp
occur aler close occur nutrit china gain
chang occur aggreg factor may
drive growth beyond feel investor expect
posit could still happen cardiomem yet
gotten ncd seem data requir
believ heartmat growth acceler could
lastli think aler accret could greater expect
compani doesnt ralli year often
valuat seem full sinc pick coverag last june
move trade bit large-cap comp point
stress test pt adjust
libr five extra cent aler neuromod growth
sinc think area could outperform appli
multipl would land us pt year smaller
beat area land low still see bit
potenti upsid feel share move anoth
valuat rate neutral risk follow page
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
valuat abbott rate neutral share appreci
last year strong new product launch expect although
like product think upsid investor expect
decreas feel target multipl ntm earn appropri
mirror histor rang last year appli
estim yield enough upsid buy rate btig
provid price target neutral-r stock
risk rate includ multipl expans competit healthcar polici
chang currenc fluctuat healthcar fall favor fda
regulatori agenc product delay failur execut merger synergi
ntm johnsonjnjsel nestlenesn-chnot novartisnvsnot rocherhhbynot thermo fishertmobuy danaherdhrnot strykersyknot danonebn-frnot bdxnot boston scientificbsxbuy baxterbaxnot zimmerzmhnot dentsplyxraynot sourc factset data btig estimatespr ex-amortcompanytickerr ptpricemarket cap bev/salesev/ebitdacagrdividend yield
abbott incom statement sale ex oper interest incom incom tax expens net ep methodology/abt share net incom ep incl disc marginsgross expensescog oper expens ep btig estim compani report
abbott segment y/i y/i y/i y/i y/i medic devic report pre-acqestablish pharmaceuticalkey emerg market y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth laboratori y/i laboratori y/i growth laboratori y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth btig estim
abbott segment devicesrhythm manag y/i manag y/i growth manag y/i growth y/i y/i growth y/i growth failur y/i failur y/i growth failur y/i growth y/i y/i growth y/i growth heart y/i heart y/i growth heart y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth devic y/i devic y/i growth devic y/i growth totaltot report segment us y/i report segment y/i report segment ww y/i btig estim compani adjust stj acquisit optic divestitur
btig cover compani mention report
appendix analyst certif import disclosur
